Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

4.3K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
4.3K
Obesity01:24

Obesity

1.4K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.4K
Nursing Interventions I: Taxonomy of Nursing Interventions01:03

Nursing Interventions I: Taxonomy of Nursing Interventions

4.0K
Nursing interventions are chosen as part of the planning process to achieve patient outcomes. Once nursing diagnoses are determined, the goals and outcomes are specified, then the nursing interventions are selected and individualized according to the patient's situation.
A nursing intervention is a treatment or action based on scientific concepts and knowledge from the nursing, behavioral, and physical sciences. Identifying and prioritizing nursing interventions based on the desired outcome...
4.0K
Excess Pressure Inside a Drop and a Bubble01:13

Excess Pressure Inside a Drop and a Bubble

3.5K
The shape of a small drop of liquid can be considered spherical, neglecting the effect of gravity. This drop can further be considered as two equal hemispherical drops put together due to surface tension. The forces acting on the spherical drop are due to the pressure of the liquid inside the drop, the pressure due to air outside the drop, and the force due to the surface tension acting on the two hemispherical drops.
3.5K
Nursing Interventions II: Selecting and Classifying the Nursing Interventions01:29

Nursing Interventions II: Selecting and Classifying the Nursing Interventions

3.4K
Creating and executing a nursing diagnosis helps nurses plan care and guide patient, family, and community interventions. They are developed based on a patient's physical evaluation and support measuring the outcomes. It is not recommended to select random interventions throughout the planning process. Instead, consider the following six essential factors when choosing interventions:
3.4K
Relative Risk01:12

Relative Risk

2.2K
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
2.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

JCF In Case You Missed It! Summary of American College of Cardiology (ACC) 2026.

Journal of cardiac failure·2026
Same author

The final common pathway: Why etiology may not be destiny in cardiogenic shock.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026
Same author

Neck Laterality and Discrepant Assessment of Right Atrial Pressure by Point-of-Care Ultrasound in Patients With Heart Failure.

Journal of cardiac failure·2026
Same author

Lipomatous hypertrophy of the atrial septum with periprocedural haemorrhage masquerading as potential malignancy: a case report.

European heart journal. Case reports·2026
Same author

Nudges in A Learning Health System: Applications to Cardiovascular-Kidney-Metabolic Care.

JACC. Advances·2025
Same author

Assessing Medical Therapy Optimization in Cardiovascular-Kidney-Metabolic Clinical Trials: An Initiative From the Heart Failure Collaboratory.

JACC. Heart failure·2025

Related Experiment Video

Updated: Feb 14, 2026

Assessing Changes in Volatile General Anesthetic Sensitivity of Mice after Local or Systemic Pharmacological Intervention
08:49

Assessing Changes in Volatile General Anesthetic Sensitivity of Mice after Local or Systemic Pharmacological Intervention

Published on: October 16, 2013

14.5K

Cardio-Obesity and Therapeutic Advances: Intersections Between Excess Adiposity, Cardiovascular Risk, and

Diana De Oliveira-Gomes1,2, Alfonso Martinez de Majo3, Angie Ardila-Delgado4

  • 1Department of Cardiology, Brigham and Women's Hospital, Boston, MA, USA.

Current Atherosclerosis Reports
|February 13, 2026
PubMed
Summary

Novel incretin agonist therapies significantly reduce weight and cardiovascular events in obesity. These medications offer a new cornerstone for managing obesity-related heart risks, improving patient outcomes.

Keywords:
Anti-Obesity medicationsCardiovascular diseaseGLP-1 receptor agonistsGLP-1/GIP receptor agonistsNutrient-Stimulated hormonesObesityPharmacologic therapyWeight-Loss

More Related Videos

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
06:04

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome

Published on: September 27, 2024

1.6K
White and Brown Adipose Grafts: An Approach to Correct Reproductive, Metabolic, and Renal Deficits in Black and Tan Brachyury (BTBR) Obese Mice
06:16

White and Brown Adipose Grafts: An Approach to Correct Reproductive, Metabolic, and Renal Deficits in Black and Tan Brachyury (BTBR) Obese Mice

Published on: September 9, 2025

472

Related Experiment Videos

Last Updated: Feb 14, 2026

Assessing Changes in Volatile General Anesthetic Sensitivity of Mice after Local or Systemic Pharmacological Intervention
08:49

Assessing Changes in Volatile General Anesthetic Sensitivity of Mice after Local or Systemic Pharmacological Intervention

Published on: October 16, 2013

14.5K
Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
06:04

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome

Published on: September 27, 2024

1.6K
White and Brown Adipose Grafts: An Approach to Correct Reproductive, Metabolic, and Renal Deficits in Black and Tan Brachyury (BTBR) Obese Mice
06:16

White and Brown Adipose Grafts: An Approach to Correct Reproductive, Metabolic, and Renal Deficits in Black and Tan Brachyury (BTBR) Obese Mice

Published on: September 9, 2025

472

Area of Science:

  • Cardiology
  • Endocrinology
  • Pharmacology

Background:

  • Obesity is a major risk factor for cardiovascular disease (CVD).
  • Understanding the link between obesity and CVD is crucial for effective management.
  • Pharmacologic therapies are evolving to address obesity-related cardiovascular risks.

Purpose of the Study:

  • To review mechanistic pathways linking obesity and cardiovascular disease.
  • To evaluate recent advancements in pharmacologic therapies for obesity.
  • To assess the integration of novel anti-obesity medications into treatment paradigms.

Main Methods:

  • Review of current literature on obesity and cardiovascular disease.
  • Analysis of clinical trial data for novel anti-obesity medications.
  • Evaluation of pharmacologic strategies alongside lifestyle interventions and bariatric surgery.

Main Results:

  • Incretin agonists (GLP-1 and dual GLP-1/GIP) demonstrate significant weight reduction (10-20%) and cardiometabolic improvements.
  • These agents lower the risk of major adverse cardiovascular events (MACE) in patients with and without diabetes.
  • Tirzepatide shows superior weight loss efficacy compared to GLP-1 monotherapy.

Conclusions:

  • Pharmacologic therapy is a central pillar in managing obesity-related cardiovascular risk.
  • Novel agents with proven efficacy in weight reduction and cardiovascular outcomes represent a paradigm shift.
  • Early and sustained use of pharmacotherapy is recommended for high-risk individuals, emphasizing integrated care.